https://www.onhealthcare.tech/p/nucleus-genomics-says-vitruvian-can-26dThoughts on Healthcare Markets & Technologyen2026-09-22T10:04:54+00:00Nucleus Genomics says Vitruvian can optimize embryo DNA for 14 IQ points: what within-family validation, five-embryo math, pleiotropy and an empty regulatory map allow it to pick smarter babieshttps://www.onhealthcare.tech/p/nucleus-genomics-says-vitruvian-canThoughts on Healthcare Markets & Technologyen2026-09-22T09:57:47+00:00Nucleus Genomics says Vitruvian can optimize embryo DNA for 14 IQ points: what within-family validation, five-embryo math, pleiotropy and an empty regulatory map allow it to deliverhttps://www.onhealthcare.tech/p/warrens-stop-corporate-takeoversThoughts on Healthcare Markets & Technologyen2026-09-21T14:38:47+00:00Warren’s Stop Corporate Takeovers of Physicians Act, the friendly PC loophole, and why a federal corporate practice of medicine ban would hit Optum harder than it hits mid-market PEhttps://www.onhealthcare.tech/p/part-ii-warrens-stop-corporate-takeoversThoughts on Healthcare Markets & Technologyen2026-09-21T11:18:23+00:00Part II: Warren's Stop Corporate Takeovers of Physicians Act, the friendly PC loophole, and why a federal corporate practice of medicine ban would hit Optum harder than it hits mid-market PEhttps://www.onhealthcare.tech/p/part-i-warrens-stop-corporate-takeoversThoughts on Healthcare Markets & Technologyen2026-09-21T11:17:13+00:00Part I: Warren's Stop Corporate Takeovers of Physicians Act, the friendly PC loophole, and why a federal corporate practice of medicine ban would hit Optum harder than it hits mid-market PE